AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 49 filers reported holding AUDENTES THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,174,000 | +110.5% | 53,035 | -1.2% | 0.00% | +100.0% |
| Q3 2019 | $1,508,000 | -18.4% | 53,687 | +10.0% | 0.00% | 0.0% |
| Q2 2019 | $1,849,000 | +234.4% | 48,825 | +244.5% | 0.00% | 0.0% |
| Q1 2019 | $553,000 | -76.2% | 14,174 | -87.0% | 0.00% | -50.0% |
| Q4 2018 | $2,319,000 | +83.2% | 108,779 | +240.0% | 0.00% | +100.0% |
| Q3 2018 | $1,266,000 | +3.7% | 31,990 | +0.1% | 0.00% | 0.0% |
| Q2 2018 | $1,221,000 | +12.1% | 31,962 | -11.8% | 0.00% | 0.0% |
| Q1 2018 | $1,089,000 | +27.8% | 36,241 | +32.9% | 0.00% | 0.0% |
| Q4 2017 | $852,000 | +2942.9% | 27,264 | +2651.2% | 0.00% | – |
| Q3 2017 | $28,000 | +1300.0% | 991 | +871.6% | 0.00% | – |
| Q2 2017 | $2,000 | -33.3% | 102 | -33.3% | 0.00% | – |
| Q1 2017 | $3,000 | – | 153 | +3725.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 4 | -99.1% | 0.00% | – |
| Q3 2016 | $8,000 | – | 469 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 767,502 | $45,927,000 | 23.65% |
| Chicago Capital Management, LLC | 250,401 | $14,984,000 | 12.57% |
| Foresite Capital Management III, LLC | 233,067 | $13,947,000 | 7.82% |
| Partner Investment Management, L.P. | 17,795 | $1,065,000 | 7.65% |
| RAMIUS ADVISORS LLC | 220,784 | $13,212,000 | 5.68% |
| Beryl Capital Management LLC | 550,426 | $32,937,000 | 5.31% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 647,460 | $38,744,000 | 5.28% |
| FNY Investment Advisers, LLC | 278,861 | $16,687,000 | 5.17% |
| WHITE SQUARE CAPITAL LLP | 112,500 | $6,732,000 | 4.87% |
| Casdin Capital, LLC | 860,000 | $51,462,000 | 4.73% |